Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA
- 1 June 1995
- Vol. 75 (11), 2757-2761
- https://doi.org/10.1002/1097-0142(19950601)75:11<2757::aid-cncr2820751120>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNAInternational Journal of Cancer, 1994
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reactionEuropean Journal of Cancer and Clinical Oncology, 1991
- Serial immunocytologic analysis of blood for tumor cells in two patients with neuroblastomaCancer, 1991
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991
- Avoiding false positives with PCRNature, 1989
- Structure of the Human Tyrosine Hydroxylase Gene: Alternative Splicing from a Single Gene Accounts for Generation of Four mRNA Types1The Journal of Biochemistry, 1988
- Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrowBritish Journal of Cancer, 1987
- A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristicsNature, 1987
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971